Physician

Aaron Lenhart, D.O.

According to 2025 Medicare claims, Aaron Lenhart, D.O. (NPI: 1710161336) practices family practice in the Pittsburgh, PA market, with the plurality of this provider's patient population coming from Beaver, PA. This provider's primary affiliated billing organization is HERITAGE VALLEY MULTISPECIALTY GROUP, INC. (NPI: 1528015401; TIN: 251775949) and primary practice location at 15001-1000. Lenhart is affiliated with the Heritage Valley Healthcare Network ACO, LLC (ACO ID: A3730) and Aledade 150 PACHC MSSP Enhanced (ACO ID: A5348), participating under the MSSP model.

Lenhart's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 92 traditional Medicare patients, billed 207 HCPCS/CPT codes, and received $15,161 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 3,661 prescription claims across 502 beneficiaries totaling $334,231 in drug costs, led by Ozempic (Semaglutide). DME data shows 37 claims. Open Payments data shows 28 records totaling $489. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have fallen sharply in recent years, from $727,163 to $334,231. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $19,678 to $1,140.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	14	27	$247
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	44	67	$4,347
2024	92	207	$15,161

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	451	9,957	$727,163
2016	466	11,355	$882,984
2017	356	9,617	$767,881
2018	370	10,106	$898,510
2019	376	9,409	$906,043
2020	363	9,168	$975,798
2021	354	8,817	$946,211
2022	371	9,330	$939,076
2023	487	7,497	$877,721
2024	502	3,661	$334,231

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	30	174	$4,865
2016	37	220	$6,566
2017	17	196	$4,097
2018	11	88	$2,348
2019	11	169	$5,474
2020	11	116	$6,085
2021	11	119	$6,337
2022	N/R	75	$3,432
2023	N/R	85	$6,690
2024	N/R	37	$4,051

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	21	21	$123
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	78	114	$73
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	28	32	$34

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	37	2,050	$66,621
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	81	2,910	$58,285
Eliquis	Apixaban	24	1,560	$29,494
Trulicity	Dulaglutide	30	846	$28,883
Jardiance	Empagliflozin	23	1,290	$23,493

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4152	Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	12	$2,910
B4034	Enteral feeding supply kit; syringe fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape	N	N/R	12	$991
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	N	N/R	13	$150

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	28	$489	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aaron Lenhart, D.O.?

Tedicare shows public-source Medicare data for Aaron Lenhart, D.O. (NPI 1710161336), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aaron Lenhart, D.O. have ACO affiliation data?

Aaron Lenhart, D.O. is shown with ACO affiliation data for Heritage Valley Healthcare Network ACO, LLC (MSSP, ACO ID A3730) and Aledade 150 PACHC MSSP Enhanced (MSSP, ACO ID A5348).

What billing organization is linked to Aaron Lenhart, D.O.?

Aaron Lenhart, D.O. is linked to HERITAGE VALLEY MULTISPECIALTY GROUP, INC. (billing NPI 1528015401) in the available physician profile data.

Does Aaron Lenhart, D.O. have Open Payments data?

Aaron Lenhart, D.O. has 28 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.